Publications by authors named "Daniela Bota"

Claim this Profile
P
Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival.
Daniela A Bota, David E Piccioni, Christopher M Duma, Santosh Kesari, Jose A Carrillo

Hum Vaccin Immunother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The concept, intention, and evaluation of the term treatment-refractory meningioma.
Lasse Rehné Jensen, Andrea Daniela Maier, Tareq A Juratli, Stéphane Goutagny, Luca Bertero, Daniela A Bota

J Neurooncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the Trajectory of Depressive Symptoms in Newly Diagnosed High-Grade Glioma Patients-A Meta-Analysis.
Shayda M Abazari, Peter G Bota, Thomas H Taylor, Daniela A Bota

Psychooncology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Digital Asthma Self-Management Program for Adults: A Randomized Clinical Trial.
Jordan Silberman, Siavash Sarlati, Bronwyn Harris, Hanson Lenyoun, Manpreet Kaur, Daniela A Bota

JAMA Netw Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of Poly-ADP ribose polymerase (PARP) enzymes in chemotherapy-induced cognitive impairments - parallels with other neurodegenerative disorders.
Dahlia A Ordaz, Kalpna Gupta, Daniela A Bota

Front Pharmacol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of the mitochondrial Lon peptidase 1 and the chymotrypsin-like proteasome activity as a potential therapeutic strategy in malignant astrocytoma models.
Christopher Douglas, Shashi Jain, Naomi Lomeli, Javier Lepe, Kaijun Di, Daniela A Bota

Pharmacol Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuronal p38 MAPK Signaling Contributes to Cisplatin-Induced Peripheral Neuropathy.
Yugal Goel, Donovan A Argueta, Kristen Peterson, Naomi Lomeli, Daniela A Bota

Antioxidants (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.
Christopher L Moertel, Angela C Hirbe, Hans H Shuhaiber, Kevin Bielamowicz, Alpa Sidhu, Daniela A Bota

J Clin Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Copanlisib in Patients With PTEN Loss: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols Z1G and Z1H.
Mohamed A Gouda, Zihan Wei, Jordi Rodon, Michael A Davies, Filip Janku, Daniela A Bota

JCO Precis Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-acetylcysteine prevents cisplatin-induced cognitive impairments in an ovarian cancer rat model.
Naomi Lomeli, Diana C Pearre, Javier Lepe, Donovan A Argueta, Mya A Arellano, Daniela A Bota

Cancer Lett· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma.
Zahra Motahari, Javier J Lepe, Malia R Bautista, Clay Hoerig, Ashley S Plant-Fox, Daniela A Bota

PLoS One· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial.
Patrick Roth, Thierry Gorlia, Jaap C Reijneveld, Filip de Vos, Ahmed Idbaih, Daniela A Bota

Neuro Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation vaccines are showing promise against glioblastoma.
Robert O Dillman, Daniela A Bota

Oncotarget· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WITHDRAWN: LonP1 Drives Proneural Mesenchymal Transition in IDH1-R132H Diffuse Glioma.
Christopher Douglas, Naomi Lomeli, Thao Vu, James Pham, Daniela A Bota

bioRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WITHDRAWN: Dual targeting of mitochondrial Lon peptidase 1 and chymotrypsin-like protease by small molecule BT317, as potential therapeutics in malignant astrocytomas.
Christopher Douglas, Shashi Jain, Naomi Lomeli, Kaijun Di, Nitesh Kumar Nandwana, Daniela A Bota

bioRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin induces BDNF downregulation in middle-aged female rat model while BDNF enhancement attenuates cisplatin neurotoxicity.
Naomi Lomeli, Diana C Pearre, Maureen Cruz, Kaijun Di, Joni L Ricks-Oddie, Daniela A Bota

Exp Neurol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical assessment of MAGMAS inhibitor as a potential therapy for pediatric medulloblastoma.
Zahra Motahari, Javier J Lepe, Malia R Bautista, Clay Hoerig, Ashley S Plant-Fox, Daniela A Bota

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of new hit to lead magmas inhibitors as potential therapeutics for glioblastoma.
Bhaskar C Das, Javier J Lepe, Mohammed Adil Shareef, Naomi Lomeli, Sasmita Das, Daniela A Bota

Bioorg Med Chem Lett· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas.
Priscilla K Brastianos, Erin Twohy, Susan Geyer, Elizabeth R Gerstner, Timothy J Kaufmann, Daniela A Bota

N Engl J Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin Induces BDNF Downregulation in Middle-Aged Female Rat Model while BDNF Enhancement Attenuates Cisplatin Neurotoxicity.
Naomi Lomeli, Diana C Pearre, Maureen Cruz, Kaijun Di, Daniela A Bota

bioRxiv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-viral precision T cell receptor replacement for personalized cell therapy.
Susan P Foy, Kyle Jacoby, Daniela A Bota, Theresa Hunter, Zheng Pan

Nature· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.
Linda M Liau, Keyoumars Ashkan, Steven Brem, Jian L Campian, John E Trusheim, Daniela A Bota

JAMA Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment.
Daniela A Bota, Thomas H Taylor, David E Piccioni, Christopher M Duma, Renato V LaRocca, Peter G Bota

J Exp Clin Cancer Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A digital approach to asthma self-management in adults: Protocol for a pragmatic randomized controlled trial.
Jordan Silberman, Siavash Sarlati, Bronwyn Harris, Warris Bokhari, Homer Boushey, Daniela A Bota

Contemp Clin Trials· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to Prophylactic Anticonvulsant Guidelines for Newly Diagnosed Brain Tumor Patients: A Quality Improvement Study.
Dan Beverly Fu, Xiao-Tang Kong, Tener Goodwin Veenema, Daniela A Bota, Binu Koirala

J Adv Pract Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis